Investment Trusts

Polar Capital Global Healthcare Trust

PCGH:LSE

Polar Capital Global Healthcare Trust

  • Price (GBX)363.00
  • Today's Change1.00 / 0.28%
  • Shares traded147.88k
  • 1 Year change9.01%
  • Beta0.6321
Data delayed at least 20 minutes, as of May 03 2024 16:35 BST.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PricePolar Capital Global Healthcare Trust (Ordinary Share)+9.80%
NAVPolar Capital Global Healthcare Trust (Ordinary Share)+10.75%
Morningstar's BenchmarkMSCI ACWI/Health Care NR GBP enhanced--

Key statistics

On Friday, Polar Capital Global Healthcare Trust (PCGH:LSE) closed at 363.00, -4.22% below its 52-week high of 379.00, set on Apr 03, 2024.
52-week range
Today
294.00Nov 07 2023379.00Apr 03 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding121.27m
Market cap439.00m GBP
Total assets508.00m GBP
Total expense ratio0.94%
High366.00
Low362.00
Previous close362.00
Average volume153.61k
YTD Change+10.00%
Beta0.6321
Diluted NAV (est)386.50
Diluted NAV (last pub)386.44
Premium/Discount-6.08%
Net Gearing+7.36%
Annual div (ADY)2.20 GBX
Annual div yield (ADY)0.61%
Div ex-dateFeb 01 2024
Div pay-dateFeb 29 2024
Data delayed at least 20 minutes, as of May 03 2024 16:35 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.